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Abstract
Purpose A prospective, multicentre, observational study
was undertaken to assess Tisseel® Wbrin sealant for atrau-
matic mesh Wxation in inguinal hernia repair throughout
France.
Methods Surgeons recorded data on patients undergoing
tension-free inguinal hernioplasty with mesh Wxation with
Tisseel®, regardless of the hernioplasty technique used.
Assessments were made at 2 days and 1 month after sur-
gery. Data on local complications, operation times and ease
of product use were collected.
Results In total, 1,201 patients were recruited (90% men,
mean age 57 years), among which 526 procedures were
performed using open techniques and 675 using laparo-
scopic repairs. Local complications occurred in 4.7% of
patients: 3.0% haematoma, 1.4% seroma, 0.3% recurrence.
The mean visual analogue scale (VAS)-rated pain scores
were 3.2 pre-operatively, 2.3 immediately after surgery and
1.8 at 1 month. Surgeons rated the product as very easy to
use.
Conclusions Tisseel® Wbrin sealant appears to be a well-
tolerated and easy-to-use alternative to traditional, tissue-
penetrating devices for mesh Wxation in hernia repair
techniques.
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Introduction
Inguinal hernia repair is the most frequently performed pro-
cedure in general surgery [1]. Over the last few years, the
placement of a prosthetic mesh in front of the hernia oriWce
has become an increasingly popular strategy to prevent
recurrence. Several techniques exist that require permanent
Wxation of the prosthesis to the abdominal wall, usually
using tissue-penetrating devices like staples or sutures.
However, such techniques can cause post-operative bleed-
ing as well as pain due to nerve compression [2, 3]. In par-
ticular, most reports of chronic pain encountered after
tension-free groin hernia repair are related to the use of
these tissue-penetrating devices [3–5].
The recognised problem of complications associated
with permanent mesh Wxation methods in groin hernio-
plasty prompted the search for other Wxation techniques.
Tisseel®1 Wbrin sealant (Baxter Healthcare, DeerWeld, Illi-
nois, USA) has been proposed as an alternative, atraumatic
method for mesh Wxation based on its eVective, proven
adhesive properties, as well as its potential additional
wound-healing properties [6–8].
Tisseel® is a biodegradable, biological preparation com-
bining highly concentrated, human plasma-derived Wbrino-
gen (75–115 mg/mL) and thrombin (500 IU/mL). The
mixing of these components in the presence of calcium
chloride leads to the development of a three-dimensional
matrix of polymerised Wbrin Wbres in a process mimicking
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the last step of biological coagulation. Fibrin sealant can,
therefore, be used as an adjuvant to haemostasis in a variety
of surgical applications [9, 10].
In 1997, Chevrel and Rath Wrst proposed Wbrin sealant as
an alternate means of mesh Wxation in hernia repair, with the
aim of reducing the rate of hernia recurrence [11]. Canonico
et al. [9] later reported the beneWts of Wbrin sealant in reduc-
ing bleeding complications following hernia repair in
patients with impaired coagulation. Katkhouda et al. [12]
have since employed a pig model using a total extraperito-
neal (TEP) technique to evaluate the tensile strength of mesh
Wxation 12 days after the use of Tisseel®, demonstrating
equal strength to staples. The results of these studies have
encouraged surgeons to use Wbrin sealant in daily practice as
an atraumatic alternative to mechanical mesh Wxation.
In France, an estimated 87,500 tension-free hernioplasty
procedures were performed in 2000 [13]. In order to assess
the feasibility of a new technique of mesh Wxation, we set
up an open, multicentre, observational study inviting sur-
geons across France to report their cases of groin hernia
repair involving the Wxation of prosthetic meshes with Tis-
seel®. It was intended that this registry of data would repre-
sent real-world surgical practice in France at the time of
introduction of a surgical sealant, in the absence of data
from large randomised controlled trials. Here, we report
data from this study focusing on the rate of recurrence,
post-operative pain and complications related to haemosta-
sis, i.e. haematoma and seroma following hernia surgery
with Tisseel® as a means of mesh Wxation.
Materials and methods
Design
This prospective, multicentre, longitudinal study was initi-
ated in 2003 by Baxter Healthcare under the guidance of a
scientiWc co-ordinator (BD). An independent clinical
research organisation was employed to monitor the study
and analyse the data collected.
French general surgeons performing at least 100 hernio-
plasty procedures per year, who were already using Wbrin
sealant for mesh Wxation, were targeted for recruitment.
This included surgeons from both private and public health-
care sectors.
Surgeons were asked to record data on adult patients who
were scheduled to undergo tension-free hernioplasty, either by
the open or laparoscopic approach, with Tisseel® for mesh
Wxation. No other criteria were stipulated by the study proto-
col other than that Tisseel® was to be used within its approved
indication. Coagulation disorders were not excluded.
The primary outcome of interest in this study of Wbrin
sealant in hernia repair relates to bleeding complications,
i.e. haematoma and seroma. These were seen to be reliable
indicators of short-term eVectiveness, given that Tisseel®’s
core indication is as an adjunct to local haemostasis. Data
from the 2003 Cochrane Collaboration systematic review
of laparoscopic versus open techniques for hernia repair by
McCormack et al. [3] indicate that the combined incidence
of haematoma and seroma (excluding bruising) following
either method of hernioplasty is approximately 14%. Based
on this value, we estimated that we needed to enrol 1,333
cases to demonstrate a 25% reduction in bleeding compli-
cations, given a power level of 80% and a 5% two-sided
signiWcance level. Other patient-centred outcome measures
studied included recurrence, pain, infections and miscella-
neous complications. Rigid deWnitions of each outcome
were not provided, as this study was intended to reXect cur-
rent practice, so classiWcations were left to the discretion of
individual investigators.
Fifty surgeons were targeted for recruitment and each
was asked to provide data on 30 cases in order to achieve
the target of 1,333 patients, allowing for around 10% drop-
out.
Assessments
Approximately 2 weeks prior to surgery, surgeons com-
pleted a questionnaire with each patient to collect the fol-
lowing data: demography, hernia risk factors (prostatism,
smoking, chronic constipation, chronic obstructive pulmo-
nary disease), type of hernia, haemostasis parameters (pro-
thrombin time, bleeding time, activated partial
thromboplastin time), pain assessment (visual analogue
scale [VAS], where 0 = no pain and 10 = unbearable pain)
and the use of analgesic treatments.
On the day of surgery, surgeons recorded the type of
anaesthesia, surgical technique, mesh, means of Wxation,
and duration of operation. They were also asked to com-
plete a VAS-graded convenience score to describe Tis-
seel®’s ease of use (where 0 = very easy and 10 = very
diYcult). Surgeons were briefed to assess and report any
post-operative complications occurring during the Wrst 48 h
following surgery.
At the one-month follow-up visit, surgeons examined
the patients for evidence of recurrence, including careful
questioning to evaluate the level of any post-operative pain
relative to pre-operative symptoms. Ultrasound imaging
was undertaken at the discretion of the surgeon if it was
thought to be necessary to conWrm recurrence. The duration
of sick leave (in non-retired patients) was assessed. Sur-
geons also completed two additional questionnaires where
appropriate: one when sutures had been used in association
with Wbrin sealant to Wx the mesh and the other to describe
the previous surgical technique that was used in case of ini-
tial recurrent hernia.Hernia (2009) 13:505–510 507
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Statistical analysis
Descriptive statistics were performed on all of the parame-
ters studied.
Ethical considerations
This study was run in accordance with the principles out-
lined in the Helsinki Declaration of 1964 and its subsequent
amendments and in keeping with the Good Clinical Prac-
tice Guide (1988 version) and article L4113-6 of the Public
Health Law of France. According to article 78-17 of French
law on the freedom of access to computerised data of 06/
01/78, the study protocol was approved by the French
Advisory Board for the Treatment of Information Related
to Research in the Health Sector and the French National
Computer Council.
According to article L4113-6 of the Public Health Safety
Law, the sponsor submitted the protocol and related docu-
ments to the National Medical Council (CNOM), who for-
warded a favourable opinion on 27 March 2003.
Each patient was provided with an informed consent
form by the operating surgeon.
Results
Collection of data
Forty-Wve surgeons from 42 public and private institutions
of varying sizes completed study questionnaires on 1,201
patients within the allocated recruitment period of 1 year.
In addition, 51 ‘associated sutures’ and 29 ‘initial recurrent
hernia’ questionnaires were completed.
Pre-operative assessment
Of the 1,201 patients, 90% were male and 47% were seden-
tary workers or retired. The mean age was 57 years, with a
mean height of 1.72 m and mean body weight of 73.8 kg. A
total of 38% of patients had at least one hernia risk factor
(among them, 39% of patients smoked and 24% had prosta-
tism). In the vast majority of cases, hernias were inguinal
(99%) and primary (93%); 79% of hernias were unilateral.
The mean pre-operative VAS pain rating was 3.2, indicat-
ing moderate pain (Table 1).
Surgical technique
General anaesthesia was performed in 84% of the cases. The
techniques used (Table 2) were fairly evenly divided between
the open approach (Lichtenstein, 34.1%; plug and patch,
4.4%; various other open techniques such as Stoppa, 5.4%)
and laparoscopic repairs (trans-abdominal pre-peritoneal
patch repair [TAPP], 28.4%; totally extraperitoneal repair
[TEP], 27.8%]. The overall mean duration of surgery was
39 min, with laparoscopic procedures taking slightly longer
than open techniques, a result consistent with other trials [3].
In total, 23 diVerent brands of mesh were used; the most
frequently used mesh was the composite Parietex (24%).
Surgeons used sutures or staples in addition to Tisseel® in
28% of patients, mainly (in 53% of cases) during Lichten-
stein repair to Wx the prosthesis to the pubic angle or to
reduce the hernia oriWce in direct hernia. Fixations were
located on the pubis or on Cooper’s ligament, generally
with one suture/staple as per standard practice. The other
reason cited for the use of sutures in addition to Tisseel®
was in order to reduce the size of the inguinal oriWce, and
not for mesh Wxation to the abdominal wall.
The amount of Wbrin glue used was 1 mL in 0.4% of
cases, 2 mL in 74.6% of cases and 5 mL in 25% of cases
(mostly for bilateral hernia). Application devices were
adapted to each kind of surgery (application needle or spray
for the open techniques, soft or rigid dual-lumen catheters
for laparoscopic techniques). Regardless of the application
device used, surgeons found that Tisseel® was easy to
apply, with a mean VAS-graded convenience score of 1.6.
Short-term follow-up
Assessed 24–48 h after surgery, patients’ mean VAS-
graded pain score was 2.3, indicating mild pain (Table 1).
Table 1 Assessment of pain on a visual analogue scale (VAS) pre-operatively, at 1–2 days and at 1 month follow-up
VAS scale: 0 = no pain, 10 = unbearable pain
a Pain >3 on the VAS is considered to be moderate or severe
Median time of assessment Number 
of answers
Number (%) 
of patients 
reporting pain
VAS score
Mean (§SD)
VAS score
Min–max
Number (%) 
of patients 
with VAS score >3a
Pre-operative (15 days before surgery) 1,158 1,049 (90.6) 3.2 (§2.1) 0–10 459 (39.6)
Short-term follow-up (2 days) 1,180 1,021 (86.5) 2.3 (§1.7) 0–10 232 (19.7)
Mid-term follow-up (34 days) 1,185 341 (28.8) 1.8 (§1.2) 0–9 25 (2.1)508 Hernia (2009) 13:505–510
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Analgesics were prescribed to 86.3% of patients reporting
pain, mainly paracetamol (63.2% of prescriptions) and dex-
tropropoxyphene (25.3% of prescriptions).
One-month follow-up
Follow-up data were collected at a median of 34 days after
surgery (Table 2). Local complications that could be inXu-
enced by the use of Wbrin sealant were recorded in 4.7% of
patients overall: 3.0% of patients had haematoma, 1.4%
seroma and 0.3% (four patients) recurrence. No cases of
neuralgia at the operating site were recorded; one infection
was noted. The mean VAS-graded pain score at that time
was 1.8. Only 2.1% of the patients scored pain >3 on the
VAS (moderate or severe). No diVerences in pain intensity
were evident between the three most used surgical tech-
niques. The mean (SD) duration of sick leave was 25.2
(13.5) days and was comparable between active and seden-
tary workers.
Discussion
Initial studies with Tisseel® Wbrin sealant as a method of
mesh Wxation in tension-free hernia repair were promising,
prompting further investigation of its utility in large, con-
trolled trials. Such a trial has recently been completed in
open inguinal hernia repair (TIMELI trial, Campanelli et al.
2007) [14], with the results expected to be published in 2009.
Tisseel® was introduced to France in 1982 and began to
be used in hernia repair from 2002, a time when French sur-
geons were performing over 87,000 hernia repair opera-
tions per year, and quickly became popular as an alternative
means of mesh Wxation. In the absence of randomised con-
trolled trial data, in 2003, it was decided to set up a registry
to collect data on the use of Tisseel® as a means of mesh
Wxation in hernioplasty, in order to assess its feasibility.
This led to the design of this large, multicentre, observa-
tional study, which concluded in 2005.
In our study of 1,201 patients, we noted the following
low rates of complications at 34 days follow-up: 3.0%
haematoma, 1.4% seroma, 0.3% short-term recurrence,
with a mean VAS pain score of 1.8. There was one infec-
tion noted, and no cases of neuralgia at the site of operation.
Since the completion of our study, many studies that
assess the use of Wbrin sealant in the most popular forms of
inguinal hernia repair have been published (Table 3). For
example, in an Italian randomised controlled trial, Lovi-
setto et al. [15] compared Wbrin sealant with staples as a
means of mesh Wxation in 197 patients undergoing TAPP
repair of inguinal or femoral hernia. At 12-month follow-
up, the mean VAS pain score (the primary endpoint) was
signiWcantly lower in the sealant group (19 vs. 26 mm;
P < 0.05). One haematoma/seroma was noted in the staples
group and one recurrence in the sealant group. In another
Italian randomised controlled trial of TAPP hernioplasty,
600 patients received Wxation with one of three diVerent
tack systems or Wbrin sealant [16]. After 1 month, no recur-
rences were observed in any group, but morbidity was gen-
erally lower with Tisseel®, with more rapid return to work
noted.
A French study by Topart et al. [17] focused on TEP
repair:  Wbrin sealant was used for mesh Wxation in 66
patients, compared with staple Wxation in 102 patients.
Adequate mesh Wxation was achieved with a lower
incidence of chronic post-operative pain with Wbrin sealant
versus staples (4.5 vs. 11.8%, respectively). Lau [18]
compared outcomes with Wbrin sealant and staple Wxation
following simultaneous bilateral TEP in 93 patients, dem-
onstrating a signiWcant reduction of analgesic consumption
in the Wbrin sealant group. There was a small increase in the
incidence of post-operative seroma, although this was not
considered to be clinically signiWcant. Finally, Olmi et al.
[19] performed intra-peritoneal onlay mesh (IPOM) Wxa-
tion with Wbrin sealant in 60 selected patients. After an
average of 23.7-months follow-up, one patient experienced
trocar-site haematoma, but no other complications were
observed.
Table 2 Surgical techniques used, duration of operation and percentage of patients experiencing complications that could be related to Wbrin seal-
ant at 34-day follow-up
TAPP trans-abdominal pre-peritoneal patch repair, TEP totally extraperitoneal repair
Patients Open techniques Laparoscopic techniques Total
Lichtenstein Plug and patch Other TAPP TEP
Number
(%)
408
(34.1)
53
(4.4)
65
(5.4)
341
(28.4)
334
(27.8)
1,201
(100)
Duration of operation (min), 
mean [SD]
33.3 [15.9] 30.8 [11.7] 40.0 [17.9] 46.0 [19.1] 39.2 [21.3] 38.8 [19.3]
Patients with haematomas 
or seromas (%)
5.4 3.8 4.9 3.0 2.7 4.4Hernia (2009) 13:505–510 509
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Regarding the Lichtenstein technique, Canonico et al.
[20] assessed the use of Wbrin sealant in 80 patients in an
Italian study with 12 months follow-up. No complications
were observed, and the use of Wbrin sealant was considered
to be eVective for the prevention of local haemorrhagic
complications after herniorrhaphy in patients with coagula-
tion disorders [9]. A Spanish study by Hidalgo et al. [21]
assessed mesh Wxation using Wbrin sealant compared with
polypropylene sutures in 55 patients treated for bilateral
hernia using the Lichtenstein technique. Fibrin sealant and
sutures were used for contralateral hernias in each patient.
Similar overall outcomes were reported in both inguinal
regions, but there was less post-operative pain and less
inXammatory reaction associated with Wbrin-Wxed hernia
repairs. Once again, there were no recurrences after 1 year
of follow-up.
The results of our observational study complement the
Wndings of other studies comparing Wbrin sealant with stan-
dard mesh Wxation methods, and suggest that Wbrin sealant
may yield fewer haematomas, seromas, recurrences and
less post-operative pain than mechanical means of mesh
Wxation. The surgeons in our study found the sealant to be
easy to use and operation times appear similar to studies
reporting on mechanical forms of mesh in both open and
laparoscopic hernia repair Wxation [3]. In terms of cost, the
price of 2 mL of Wbrin sealant (the most commonly used
dosage) is similar to that of staples. Clearly, large con-
trolled trials are needed to conWrm or disprove these prom-
ising indications and we eagerly await the results of the
TIMELI trial.
In terms of study limitations, we achieved only 90% of
the target patient population before the end of the 1-year
recruitment period precluded further enrolment. However,
a cohort of 1,201 patients still represents a very large
sample.
Given the design of this study, some other limitations
deserve mention. In particular, the short-term follow-up is a
major shortcoming, and a comprehensive attempt to obtain
12-month follow-up data would have yielded worthwhile
information. Perhaps one might have expected to see
slightly higher recurrence rates at 12-months follow-up. It
is also possible that some small seromas or haematomas
may have arisen and resolved between the 2- and 34-day
follow-up assessments. The absence of a pre-deWned classi-
Wcation system for each complication may also be criti-
cised, as might be the absence of standardised operating
procedures, including precise methods for mesh Wxation.
However, it is important to remember that this study was
initiated to collect data reXecting the widespread use of Tis-
seel® for hernia repair in day-to-day surgical practice in
2003–2004, in the absence of randomised control data. This
is the Wrst study of its type in France and remains the largest
of its kind in this country. Data from 42 institutions were
collected, providing a robust and highly generalisable rep-
resentation of Tisseel® use in hernia surgery from across
the nation.
Conclusion
With a total of 1,201 patients enrolled, this study is the only
large-scale French study on the use of Wbrin sealant in her-
nia repair and provides epidemiological support for the use
of Tisseel® Wbrin sealant in the Wxation of prosthetic mesh
during groin hernia repair. Fibrin sealant is an appropriate,
atraumatic, easy-to-use alternative to the traditional, tissue-
penetrating mesh Wxation devices used during common her-
nia repair techniques (Lichtenstein, totally extraperitoneal
repair [TEP] and trans-abdominal pre-peritoneal patch
repair [TAPP]). In our study, the use of Tisseel® was asso-
ciated with a very low recurrence rate (0.3%), as well as a
low rate of local complications (4.7% overall), and few
patients experienced post-operative pain at 1-month follow-
up, which has an important impact on the overall patient
Table 3 Recently published prospective studies on the use of Wbrin sealant in hernia repair, by surgical technique
TAPP trans-abdominal pre-peritoneal patch repair, TEP totally extraperitoneal repair, IPOM intra-peritoneal onlay mesh
a Randomised controlled trial
Technique Author [references] Year Number of 
patients 
(hernias) treated
Follow-up 
(months)
Recurrence Haematoma Chronic 
pain
TAPP Lovisetto et al. [15]a 2007 99 12 1.0% 0 1.0%
TAPP Olmi et al. [16]a 2007 600 (803) 1 0 – –
TEP Topart et al. [17] 2005 66 23.9 1.5% 4.5% 4.5%
TEP Lau [18]a 2005 46 14.4 0 – 13.2%
IPOM Olmi et al. [19] 2007 60 (61) 23.7 0 1 patient –
Lichtenstein Canonico et al. [20]2 0 0 5 8 0 1 2 0 0 2 . 5 %
Lichtenstein Hidalgo et al. [21] 2005 55 12 0 0.02% 0510 Hernia (2009) 13:505–510
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satisfaction with surgery. Fibrin sealant appears to be a
promising alternative to stapling/suturing for mesh Wxation
during inguinal hernioplasty. The results of large random-
ised trials such as the TIMELI trial are keenly anticipated.
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Appendix
Members of the French Tisseel®/Tissucol® study group in
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Cahors; Olivier Baubion, Sarcelles; Marc Bertaux,
Gonesse; Jean-Pierre Bobois, Niort; Norbert Boumal, Dax;
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Seclin; Michel Debaert, Lille; Hervé Delacroix, Marcq-en-
Baroeul; Dominique Delarue, Saint Grégoire; Yves Der-
nier, Sens; François-Charles Desmaizières, Paray le
Monial; Didier Dromer, Saint-Quentin; Philippe Espalieu,
Saint-Etienne; Florent Gerdil, Valence; Jean-André Gioan,
La Valette du Var; Fouzi Lachachi, Limoges; Georges Mar-
achly, Drancy; Frédéric Martin, Bar le Duc; Jean-Chris-
tophe Martinot, Lille; Jean-Loup Massard, Châlon-sur-
Saône; Franck Maisonnette, Limoges; Pierre Mazarguil,
Nice; Philippe Roge, Mainvilliers; Christian Rohr, Stras-
bourg; Christian Rosburger, Talant; Stéphane Rossi,
Rouen; Yves Russier, Carpentras; Michel Sage, Auxerre;
Bassam Tantawi, Quincy-sous-Sénart; Philippe Topart,
Angers; Jacques Tussiot, Rosny-sous-Bois; Patrick Van
Box Som, Lyon; Sorin Vartolomei, Nice; Michel Vazeux,
Fontainebleau; Constantin Zaranis, La Rochelle.
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